The lowered price target from $40 to $30 by a major financial institution like Goldman Sachs is likely to have a negative short-term impact on Symbotic's stock price. The Neutral rating suggests no strong buy or sell recommendation, but the reduced price target indicates lowered expectations for the stock's performance.